.
.
Sažetak
.
Reference
2. Qian K, Xu H, Chen Z, Zheng Y. Advances in pulmonary rehabilitation for children with bronchial asthma. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(4):518-25.
3. Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(6):1469-85.
4. Thomas D, McDonald VM, Pavord ID, Gibson PG. Asthma remission: what is it and how can it be achieved? Eur Respir J. 2022;60(5).
5. Chung KF, Dixey P, Abubakar-Waziri H, Bhavsar P, Patel PH, Guo S, et al. Characteristics, phenotypes, mechanisms and management of severe asthma. Chin Med J (Engl). 2022;135(10):1141-55.
6. Pelaia C, Heffler E, Crimi C, Maglio A, Vatrella A, Pelaia G, et al. Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets. Front Pharmacol. 2022;13:851940.
7. Roeb E. Interleukin-13 (IL-13)-A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis. Int J Mol Sci. 2023;24(16).
8. Carlberg C, Raczyk M, Zawrotna N. Vitamin D: A master example of nutrigenomics. Redox Biol. 2023;62:102695.
9. Gaudet M, Plesa M, Mogas A, Jalaleddine N, Hamid Q, Al Heialy S. Recent advances in vitamin D implications in chronic respiratory diseases. Respir Res. 2022;23(1):252.
10. Ganmaa D, Enkhmaa D, Nasantogtokh E, Sukhbaatar S, Tumur-Ochir KE, Manson JE. Vitamin D, respiratory infections, and chronic disease: Review of meta-analyses and randomized clinical trials. J Intern Med. 2022;291(2):141-64.
11. Wang FX, Jin LW. Research on the Mechanism and Application of Acupuncture Therapy for Asthma: A Review. J Asthma Allergy. 2024;17:495-516.
12. Gupta N, Malhotra N, Kunal S, Ish P. Management of bronchial asthma in 2021. Monaldi Arch Chest Dis. 2022;92(4).
13. Abe Y, Suga Y, Fukushima K, Ohata H, Niitsu T, Nabeshima H, et al. Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma. Int J Mol Sci. 2021;23(1).
14. Nikolskii AA, Shilovskiy IP, Barvinskaia ED, Korneev AV, Sundukova MS, Khaitov MR. Role of STAT3 Transcription Factor in Pathogenesis of Bronchial Asthma. Biochemistry (Mosc). 2021;86(11):1489-501.
15. Chetty VV, Chetty M. Potential benefit of vitamin D supplementation in people with respiratory illnesses, during the COVID-19 pandemic. Clin Transl Sci. 2021;14(6):2111-6.
16. Mathyssen C, Gayan-Ramirez G, Bouillon R, Janssens W. Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. Pol Arch Intern Med. 2017;127(11):775-84.
17. Maes K, Serre J, Mathyssen C, Janssens W, Gayan-Ramirez G. Targeting Vitamin D Deficiency to Limit Exacerbations in Respiratory Diseases: Utopia or Strategy With Potential? Calcif Tissue Int. 2020;106(1):76-87.
18. Wang C, Jiang Y, Fan Z, Zhao M, Jiang Y, Wang Z, et al. The efficacy of Tuina for asthma: A protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2020;99(52):e23912.
19. Mao H, Wei YH, Su HM, Jiang ZY, Li X. Pediatric Tui Na for cough in children: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2022;71:102882.
20. Alwarith J, Kahleova H, Crosby L, Brooks A, Brandon L, Levin SM, et al. The role of nutrition in asthma prevention and treatment. Nutr Rev. 2020;78(11):928-38.
21. Muszynski T, Polak K, Fratczak A, Miziolek B, Bergler-Czop B, Szczepanik A. Vitamin D-The Nutritional Status of Post-Gastrectomy Gastric Cancer Patients-Systematic Review. Nutrients. 2022;14(13).
22. Zhang J, Cao ZB. Exercise: A Possibly Effective Way to Improve Vitamin D Nutritional Status. Nutrients. 2022;14(13).
23. Kokturk N, Baha A, Oh YM, Young Ju J, Jones PW. Vitamin D deficiency: What does it mean for chronic obstructive pulmonary disease (COPD)? a compherensive review for pulmonologists. Clin Respir J. 2018;12(2):382-97.
24. Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int. 2020;69(2):178-86.
25. Saraiva M, Vieira P, O'Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1).
Sva prava zadržana (c) 2025 Li Qin

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
